Fundraising FoxVenrock — 2016 Investments
6 investments dated 2016 · listed companies and verified rows first · show all
Ligand is a royalty aggregator that finances late-stage clinical development and commercialization programs for biopharmaceutical companies.
BiotechFintechLa Jolla, US
Brook Byers(Co-founder)inMATTHEW W. FOEHR(Director)JOHN L. HIGGINS(Executive Officer, Director)inMATTHEW KORENBERG(Director)inCHARLES S. BERKMAN(Director)inTodd Davis(Chief Executive Officer)in
Co-investorsSignet Healthcare PartnersSofinnova Ventures
Real-time asset tracking and workflow monitoring in healthcare
San Diego, US
Brandon Hull(Director)Timothy Roche(Executive Officer, Director)Terry Linn(Director)Emily Wilson(Executive Officer)Paul Wallace(Director)inDana Mead(Director)
Board seatBrian Ascher· per SEC Form D · $1.9M raise · filed Aug 2017
Co-investorsHeritage GroupIcon VenturesRex Health VenturesKleiner PerkinsNew Leaf Venture Partners
Personal Capital provides wealth management and investment advisory services, offering personalized portfolio strategy, retirement planning, and tax-optimized investment management for individual investors.
FintechSan Carlos, US
William H Harris(Executive Officer, Director)Paul Bergholm(Founder)Mike Armsby(Executive Officer)Jay Shah(Executive Officer, Director)Bill Harris(Founder)Louie Gasparini(Founder)
Board seatBrian Ascher· per SEC Form D
Co-investorsCorrelation VenturesCrosslink CapitalIVP (Institutional Venture Partners)New York Life VenturesPropel Venture PartnersBlumberg Capital+2 more
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases.
BiotechDigital HealthHealthtechCambridge, US
PETER M. HECHT(Executive Officer, Director)inMARK G. CURRIE(Executive Officer)inHALLEY E. GIBLERT(Executive Officer)THOMAS GRANEY(Executive Officer)THOMAS A. MCCOURT(Executive Officer)in
BoardTERRANCE G. MCGUIRE(Director)
Co-investorsF-Prime CapitalMountain Group CapitalRidgeback CapitalMaverick VenturesPolaris Partners
Menlo Park, US
Duke Rohlen(Chief Executive Officer)
BoardCamille Samuels(Director)Anthony Natale(Director)inReed Gaither(Director)Aftab Kherani(Director)Ron Kuppersmith(Director)
Co-investorsAisling CapitalAPERTURE Venture PartnersCorrelation VenturesWestern Technology InvestmentHealthQuest Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Amino Apps
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.